NEOPLASMS BY SITE

Clinical trials for NEOPLASMS BY SITE explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS BY SITE trials appear

Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 7 Completed 4 Terminated 3

Could existing cancer drugs work for more rare tumors?

Disease control Not yet recruiting

This study tests whether two approved drugs, dabrafenib and trametinib, can shrink or control rare cancers that have a specific genetic change called BRAF V600. About 30 adults and children with various rare cancers will receive the drug combination. The goal is to see if these d…

Matched conditions: NEOPLASMS BY SITE

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Jun 16, 2026 12:50 UTC

NEOPLASMS BY SITE

Get alerted when new NEOPLASMS BY SITE trials appear

Could existing cancer drugs work for more rare tumors?